Pediatric Safety Review: Xyzal ( levocetirizine)

First Page		Document Content
Ethers Piperazines Pfizer Cetirizine Johnson & Johnson Ebastine Chemistry Organic chemistry Organochlorides		Pediatric Safety Review: Xyzal ( levocetirizine) Add to Reading List Source URL: www.fda.gov Download Document from Source Website File Size: 184,49 KB Share Document on Facebook

	SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Loradis ** 10 mg tablets 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains 10 mg loratadine. Excipient with known effect: DocID: 16VRA - View Document
	SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Lorapharm ** 10 mg tablets 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains 10 mg loratadine. Excipient with known effect: DocID: 16NlY - View Document
	SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Allergostad** 10 mg tablets 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains 10 mg loratadine. Excipient with known effect: DocID: 16yDS - View Document
	SYMPOSIUM REPORT SUPPLEMENT Pharmacology of Antihistamines Diana S. Church, MD, and Martin K. Church, PhD, DSc Abstract: This article reviews the molecular biology of the interaction of histamine with its H1-receptor a DocID: 15UWv - View Document
	1. NAME OF THE MEDICINAL PRODUCT Histasin 10 mg film-coated tablets DocID: 15dUM - View Document